These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28597865)

  • 1. Adoption of the 2015 World Health Organization guidelines on antiretroviral therapy: Programmatic implications for India.
    Rewari BB; Agarwal R; Shastri S; Nagaraja SB; Rathore AS
    WHO South East Asia J Public Health; 2017 Apr; 6(1):90-93. PubMed ID: 28597865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How many people living with HIV will be additionally eligible for antiretroviral treatment in Karnataka State, India as per the World Health Organization 2013 guidelines?
    Dodderi SK; Kumar AM; Naik BR; Kanchar A; B B R; Harries AD
    PLoS One; 2014; 9(9):e107136. PubMed ID: 25192338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines.
    Nelson LJ; Beusenberg M; Habiyambere V; Shaffer N; Vitoria MA; Montero RG; Easterbrook PJ; Doherty MC
    AIDS; 2014 Mar; 28 Suppl 2():S217-24. PubMed ID: 24849481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of antiretroviral treatment services in India: Estimated costs incurred under the National AIDS Control Programme.
    Agarwal R; Rewari BB; Shastri S; Nagaraja SB; Rathore AS
    WHO South East Asia J Public Health; 2017 Apr; 6(1):94-98. PubMed ID: 28597866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will adoption of the 2010 WHO ART guidelines for HIV-infected TB patients increase the demand for ART services in India?
    Kumar AM; Gupta D; Rewari BB; Bachani D; Mohammed S; Sharma V; Lal K; Reddy HR; Naik B; Prasad R; Yaqoob M; Deepak KG; Shastri S; Satyanarayana S; Harries AD; Chauhan LS; Dewan P
    PLoS One; 2011; 6(9):e24297. PubMed ID: 21931674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.
    Bigna JJ; Plottel CS; Koulla-Shiro S
    Infect Dis Poverty; 2016 Sep; 5(1):85. PubMed ID: 27593965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-infected presumptive tuberculosis patients without tuberculosis: How many are eligible for antiretroviral therapy in Karnataka, India?
    Kumar AMV; Singarajipura A; Naik B; Guddemane DK; Patel Y; Shastri S; Kumar S; Deshmukh R; Rewari BB; Harries AD
    J Epidemiol Glob Health; 2017 Mar; 7(1):11-19. PubMed ID: 26821235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing advanced HIV disease and mortality in global HIV programming.
    Boyd AT; Oboho I; Paulin H; Ali H; Godfrey C; Date A; Sean Cavanaugh J
    AIDS Res Ther; 2020 Jul; 17(1):40. PubMed ID: 32650797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health systems' responses to the roll-out of antiretroviral therapy (ART) in India: a comparison of two HIV high-prevalence settings.
    Kudale A; Salve S; Rangan S; Kielmann K
    AIDS Care; 2010; 22 Suppl 1(S1):85-92. PubMed ID: 20680863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples.
    Gupta S; Granich R; Suthar AB; Smyth C; Baggaley R; Sculier D; Date A; Desai MA; Lule F; Raizes E; Blanc L; Hirnschall G
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):e87-97. PubMed ID: 23187942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of the Treat All Policy Among Persons with HIV Infection Enrolled in Care But Not on Antiretroviral Therapy - India, May 2017-June 2018.
    Mitruka K; Bamrotiya M; Agarwal R; Parvez A; Allam RR; Sivalenka S; Deoraj P; Prasad R; Devi U; Keskar P; Acharya S; Kannan P; Ganti R; Shah M; Todmal S; Kumar P; Chava N; Rao A; Tanwar S; Nyendak M; Ellerbrock T; Holtz TH; Gupta RS
    MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(47):1305-1309. PubMed ID: 31199351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaling up antiretroviral treatment services in Karnataka, India: impact on CD4 counts of HIV-infected people.
    Shastri S; Boregowda PH; Rewari BB; Tanwar S; Shet A; Kumar AM
    PLoS One; 2013; 8(8):e72188. PubMed ID: 23951294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The next generation of the World Health Organization's global antiretroviral guidance.
    Hirnschall G; Harries AD; Easterbrook PJ; Doherty MC; Ball A
    J Int AIDS Soc; 2013 Jun; 16(1):18757. PubMed ID: 23819908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries.
    Ambia J; Renju J; Wringe A; Todd J; Geubbels E; Nakiyingi-Miiro J; Urassa M; Lutalo T; Crampin AC; Kwaro D; Kyobutungi C; Chimbindi N; Gomez-Olive FX; Tlhajoane M; Njamwea B; Zaba B; Mee P
    BMC Health Serv Res; 2017 Nov; 17(1):758. PubMed ID: 29162065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of WHO guidelines on trends in HIV testing and ART initiation among children living with HIV in Zambia.
    Munthali T; Michelo C; Mee P; Moyo C; Kashoka A; Liswaniso L; Chiboma I; Todd J
    AIDS Res Ther; 2020 May; 17(1):18. PubMed ID: 32408890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.